Aqua Pharmaceuticals, An Almirall Company
Pharmaceuticals, 707 Eagleview BLVD, Exton, Pennsylvania, 19341, United States, 51-200 Employees
Phone Number: +16*********
Who is AQUA PHARMACEUTICALS, AN ALMIRALL COMPANY
Aqua Pharmaceuticals is a specialty dermatology company focusing on acquiring, developing and marketing prescription medical dermatology products in the United States. Currently marketed ...
Read More
-
Headquarters: 707 Eagleview BLVD, Exton, Pennsylvania, 19341, United States
-
Date Founded: 2004
-
Employees: 51-200
-
Revenue: $50 Million to $100 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 5912
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from AQUA PHARMACEUTICALS, AN ALMIRALL COMPANY
Aqua Pharmaceuticals, an Almirall Company Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Aqua Pharmaceuticals, an Almirall Company
Answer: Aqua Pharmaceuticals, an Almirall Company's headquarters are located at 707 Eagleview BLVD, Exton, Pennsylvania, 19341, United States
Answer: Aqua Pharmaceuticals, an Almirall Company's phone number is +16*********
Answer: Aqua Pharmaceuticals, an Almirall Company's official website is https://aquapharm.com
Answer: Aqua Pharmaceuticals, an Almirall Company's revenue is $50 Million to $100 Million
Answer: Aqua Pharmaceuticals, an Almirall Company's SIC: 5912
Answer: Aqua Pharmaceuticals, an Almirall Company's NAICS: 325412
Answer: Aqua Pharmaceuticals, an Almirall Company has 51-200 employees
Answer: Aqua Pharmaceuticals, an Almirall Company is in Pharmaceuticals
Answer: Aqua Pharmaceuticals, an Almirall Company contact info: Phone number: +16********* Website: https://aquapharm.com
Answer: Aqua Pharmaceuticals is a specialty dermatology company focusing on acquiring, developing and marketing prescription medical dermatology products in the United States. Currently marketed products include: ACTICLATE (doxycycline hyclate USP) Tablets, CORDRAN (flurandrenolide USP) Lotion, Cream, and Ointment, 0.05%, FLUOROPLEX (fluorouracil) 1% Topical Cream, XOLEGEL (ketaconazole) Gel, 2%, VERDESO (desonide) Foam, 0.05%, and MONODOX (doxycycline monohydrate) Capsules. An essential element in Aqua's strategy for strong, sustainable growth is to build beyond the current product portfolio by developing, licensing, and acquiring products for the treatment of skin conditions. Importantly, Aqua looks to expand its opportunities through product development, in-licensing, co-promotion, product or company acquisition, and partnerships. In December 2013, Almirall S.A. entered into a definitive agreement to acquire Aqua Pharmaceuticals. Almirall is a pharmaceutical company committed to provide valuable medicines through its own R&D efforts together with external partnerships, licenses, and collaborations. Through seeking innovative medicines, Almirall aims to be a relevant player in dermatology, in addition to having a strong interest in gastroenterology and pain. With more than 3,000 employees in 23 countries, Almirall generated total revenues of 825 million in 2013. The company was founded in 1943 and is headquartered in Barcelona, Spain. The stock is traded on the Spanish stock exchange (ticker: ALM).
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month